Platform
Company
Drug Monitoring
Review status
Currently under review
Pending specialist review and validation.
Carbamazepine testing measures the amount of the medicine carbamazepine in your blood. This medicine is used to help control seizures, relieve certain types of nerve pain, and as a mood stabilizer. The test is part of therapeutic drug monitoring, which checks how much of the drug is in your system so it can work well while staying safe for you.
The blood sample is usually collected just before your next dose, sometimes called a trough. Testing at a consistent time in your dosing cycle gives a clearer picture of your steady level with your current dose, schedule, and formulation.
Carbamazepine has a narrow window where it is effective without causing side effects. If the level is too low, seizures or pain may not be controlled. If the level is too high, you may experience dizziness, double vision, unsteadiness, sleepiness, nausea, or more serious problems such as liver irritation or changes in blood counts.
Your clinician may order this test when starting treatment, after a dose change, if you add or stop another medicine, during pregnancy, if you have new or worsening symptoms, or to check how regularly you are able to take doses. Carbamazepine can speed up its own breakdown over time and interacts with many drugs and supplements, so periodic monitoring helps keep treatment effective and safe.
Your result will be interpreted together with why you take carbamazepine, your dose, when the sample was drawn relative to dosing, and how you are feeling. If your level is below the target for you, your clinician may increase the dose, adjust timing or formulation, review missed doses, or look for interactions that lower levels. If your level is above the target for you, the dose may be reduced or the schedule changed, and you will be monitored for side effects.
Do not change your dose on your own. Tell your clinician about all prescription and over the counter medicines, supplements, and alcohol use. Additional safety labs, such as liver tests, sodium, and blood counts, may be checked. Seek care promptly if you develop a widespread rash, severe dizziness, fainting, confusion, or signs of infection.
Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.
For most people the sample should be drawn just before your next dose to reflect a trough level. Drawing too soon after a dose or at varying times can make results hard to compare.
Many medicines and supplements change how your body processes carbamazepine. Antifungals, certain antibiotics, some heart and HIV medicines, grapefruit products, and valproate can raise levels; rifampin, phenytoin, phenobarbital, topiramate, and St John’s wort can lower them.
During ongoing therapy your liver enzymes can become more active and break down carbamazepine faster, which can lower levels even if your dose stays the same. Follow up testing helps adjust for this.
Liver disease or heavy alcohol use can change drug metabolism and increase the risk of side effects, which may require closer monitoring or dose changes.
Children often clear the drug faster, pregnancy can increase clearance, and older adults may clear it more slowly. Illness, weight changes, or hormonal shifts can also affect levels.
Immediate release and extended release products behave differently in the body. Missed doses, vomiting, or diarrhea can lower levels and reduce benefit.
Using the same laboratory, keeping collection times consistent, and proper sample handling improve comparability. Wrong tubes, delays, or sample mix ups can affect results.
References